Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Naperol Investments

₹894.9 42.2 | 4.9%

Market Cap ₹514 Cr.

Stock P/E 120.4

P/B 0.5

Current Price ₹894.9

Book Value ₹ 1835.3

Face Value 10

52W High ₹2415

Dividend Yield 0.11%

52W Low ₹ 801

Naperol Investments Research see more...

Overview Inc. Year: 1954Industry: Chemicals

National Peroxide Ltd is a producer of compressed hydrogen gas, hydrogen peroxide, sodium perborate, and per acetic acid. The Company operates via two divisions: production of peroxygens and hydrogen gas, and others, which consists of investing activities. It manufactures hydrogen peroxide with an capacity of 95,000 metric tons per annum (MTPA) on 50% weight per weight (w/w). Basis and in about 4 special forms, which consist of 50% w/w (Concentrated), 60% w/w (Concentrated), 35% w/w (Concentrated) and 70% w/w (Distillate). The Company's included production website for hydrogen peroxide is positioned at Kalyan in Maharashtra (India). The Company's subsidiary is Naperol Investments Ltd.

Read More..

Naperol Investments Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Naperol Investments Quarterly Results

#(Fig in Cr.) Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Sep 2023 Dec 2023 Mar 2024
Net Sales 69 77 66 70 99 0 1 0
Other Income 1 2 3 3 3 0 0 0
Total Income 71 79 69 72 102 0 1 0
Total Expenditure 53 49 38 38 41 0 0 1
Operating Profit 18 29 31 34 61 -0 1 -1
Interest 1 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 0 0 0
Exceptional Income / Expenses -8 0 1 0 0 0 0 0
Profit Before Tax 8 27 29 32 58 -0 1 -1
Provision for Tax 2 9 10 11 21 -0 0 -0
Profit After Tax 5 18 19 21 37 -0 1 -1
Adjustments -5 -18 -19 -21 -37 0 0 0
Profit After Adjustments 0 0 0 0 0 -0 1 -1
Adjusted Earnings Per Share 9 31.2 33.3 36.1 64.9 -0 0.9 -1

Naperol Investments Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 212 235 196 234 232 306 402 191 214 0 2 100
Other Income 5 6 6 8 6 10 19 18 13 0 0 3
Total Income 217 241 203 242 238 316 421 209 227 0 2 103
Total Expenditure 146 174 174 198 163 161 175 166 170 3 2 42
Operating Profit 72 67 28 44 76 155 245 43 57 -3 -0 61
Interest 0 0 5 5 2 1 1 3 13 0 0 0
Depreciation 11 10 7 9 9 9 9 11 17 0 0 2
Exceptional Income / Expenses 0 1 0 -1 -8 1 0 0 -15 5 376 0
Profit Before Tax 60 58 16 29 57 146 235 29 12 2 376 58
Provision for Tax 21 20 10 11 19 51 82 12 -9 1 1 21
Profit After Tax 40 39 6 18 38 95 153 17 21 1 375 37
Adjustments 0 0 0 0 0 0 0 0 0 4 0 -37
Profit After Adjustments 40 39 6 18 38 95 153 17 21 5 375 0
Adjusted Earnings Per Share 69.3 67.2 10.8 31.3 65.9 165.5 266.3 30.2 36.2 1.1 653 64.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% -78% -63% -37%
Operating Profit CAGR 0% -100% -100% -100%
PAT CAGR 37400% 180% 32% 25%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -37% -28% -19% 7%
ROE Average 69% 24% 21% 18%
ROCE Average 63% 22% 22% 23%

Naperol Investments Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 178 207 209 220 374 509 615 486 588 537 557
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 30 10 0 0 70 0 0 14 0
Other Non-Current Liabilities 95 94 108 117 27 36 40 216 216 215 179
Total Current Liabilities 41 62 76 49 38 39 59 217 160 107 1
Total Liabilities 314 363 423 396 440 585 784 919 964 873 737
Fixed Assets 110 117 187 180 178 170 166 372 342 338 0
Other Non-Current Assets 90 131 93 96 133 205 285 357 457 412 734
Total Current Assets 113 115 143 120 129 210 333 190 164 123 3
Total Assets 314 363 423 396 440 585 784 919 964 873 737

Naperol Investments Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 3 11 2 7 0
Cash Flow from Operating Activities 41 28 21 22 59 94 148 16 61 9 1
Cash Flow from Investing Activities -29 -21 -75 29 -31 -56 -175 -38 -7 34 1
Cash Flow from Financing Activities -12 -7 54 -51 -28 -35 35 14 -49 -49 -3
Net Cash Inflow / Outflow 0 0 0 -0 -0 3 8 -9 4 -6 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 3 11 2 7 0 0

Naperol Investments Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 69.27 67.2 10.85 31.27 65.92 165.51 266.28 30.22 36.21 1.13 652.95
CEPS(Rs) 88.41 84.14 23.4 46.85 81.45 181.5 282.35 49.76 66.66 1.13 652.95
DPS(Rs) 15 15 5 10 34 65 65 12.5 12.5 5 1
Book NAV/Share(Rs) 309.82 359.46 363.57 382.8 651.13 885.42 1070.28 846.45 1023.87 934.82 969.77
Core EBITDA Margin(%) 28.07 23.35 9.97 13.77 26.64 46.08 56.32 13.12 19.91 -1036.4 -12.65
EBIT Margin(%) 25.61 22.45 9.64 13.09 22.65 46.71 58.78 16.64 10.9 529.37 0
Pre Tax Margin(%) 25.46 22.37 7.5 11.02 21.81 46.55 58.6 15.21 5.26 529.37 0
PAT Margin (%) 16.77 14.8 2.85 6.9 14.48 30.28 38.12 9.11 9.28 225.37 0
Cash Profit Margin (%) 21.4 18.53 6.14 10.34 17.9 33.21 40.41 15 17.07 225.37 0
ROA(%) 13.96 11.42 1.59 4.39 9.07 18.57 22.37 2.04 2.21 0.07 46.61
ROE(%) 24.4 20.08 3 8.38 12.75 21.54 27.23 3.15 3.87 0.12 68.57
ROCE(%) 36.55 30.07 8.56 12.81 18.65 32.82 39.21 4.73 3.59 0.23 63.29
Receivable days 43.08 44.87 58.09 48.92 45.93 50.21 38.11 60.16 45.62 0 1917.76
Inventory Days 14.72 22.5 33.34 21.1 17.59 15.01 21.15 53.81 33.64 0 0
Payable days 156.92 130.94 117.68 98.56 112.4 87.67 93.14 94.65 91.11 0 0
PER(x) 6.46 6.41 51.76 17.74 14.87 14.12 10.58 38.83 60.58 1408.3 1.9
Price/Book(x) 1.44 1.2 1.54 1.45 1.51 2.64 2.63 1.39 2.14 1.7 1.28
Dividend Yield(%) 3.35 3.48 0.89 1.8 3.47 2.78 2.31 1.07 0.57 0.32 0.08
EV/Net Sales(x) 1.21 1.07 2.01 1.49 2.47 4.38 4.19 4.37 6.43 3494.93 375.67
EV/Core EBITDA(x) 3.58 3.73 13.95 7.93 7.56 8.65 6.87 19.39 23.99 -337.22 -2986.89
Net Sales Growth(%) 37.82 10.49 -16.3 18.97 -0.53 31.53 31.4 -52.52 12.5 -99.87 558.14
EBIT Growth(%) 54.71 -3.61 -64.01 61.61 73.84 147.63 60.84 -86.55 -22.94 -93.78 0
PAT Growth(%) 44.85 -2.99 -83.86 188.23 110.8 151.08 60.89 -88.65 19.84 -96.89 0
EPS Growth(%) 44.85 -2.99 -83.86 188.23 110.8 151.08 60.89 -88.65 19.84 -96.89 0
Debt/Equity(x) 0.01 0.02 0.35 0.14 0.03 0 0.13 0.33 0.21 0.17 0
Current Ratio(x) 2.78 1.84 1.88 2.45 3.36 5.32 5.69 0.87 1.03 1.15 2.18
Quick Ratio(x) 2.58 1.46 1.67 2.17 3.07 4.95 5.28 0.76 0.92 0.88 2.18
Interest Cover(x) 175.08 270.65 4.5 6.33 26.81 290.04 322.89 11.59 1.93 0 0
Total Debt/Mcap(x) 0 0.02 0.23 0.1 0.02 0 0.05 0.24 0.1 0.1 0

Naperol Investments Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 70.76 70.76 70.76 70.76 70.76 70.76 70.76 70.76 70.76 70.76
FII 0 0 0 0 0 0 0 0.07 0 0
DII 0.25 0.25 0.25 0.27 0.27 0.01 0.01 0.01 0.01 0.01
Public 28.99 28.99 28.99 28.97 28.97 29.23 29.23 29.16 29.23 29.23
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.5 times its book value
  • Company has delivered good profit growth of 31% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Naperol Investments News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....